Clinical Research

Urea Cycle Disorders Consortium

Yale is part of consortium engaged in collaborative clinical research in the incidence, outcome, and treatment of inherited disorders of ammonia metabolism. Enrollment expected to open by March 2006.

• Principal Investigator: Margretta R. Seashore, MD

Phenylketonuria: Response to Phenoptin

Yale is part of consortium engaged in collaborative clinical research in the response of phenylketonuria to supplementation with tetrahydrobiopterin. Enrollment for the current trial is closed, but inquiries about the next protocol are welcome. For more information, contact Tamar Edelkind.

• Principal Investigator: Margretta R. Seashore, MD
• Nurse Coordinator:Tamar Edelkind, APRN